October 8, 2015
US FDA announces updated drug shortages list
U.S. Food & Drug Administration (FDA) has updated information on Drug Shortages.
Pharmaceuticals, Biotechnology and Life Sciences
Category: North America
October 7, 2015
Federal judge issues permanent injunction against South Dakota’s 2035 Inc
A federal judge in the U.S. District Court for the District of South Dakota yesterday granted the U.S. Food and…
October 7, 2015
Lilly Joins the Imaging Dementia – Evidence for Amyloid Scanning (IDEAS) Study
Eli Lilly and Company and Avid Radiopharmaceuticals, Inc., a wholly owned subsidiary of Lilly, have announced financial commitment and continued scientific partnership to support the recently established Imaging Dementia – Evidence for Amyloid Scanning (IDEAS) Study.
October 6, 2015
VIDEO – Take a look at the U.S. government’s response in addressing Ebola in the United States.
Watch a video and take a look at the U.S. government’s response in addressing Ebola in the United States.
October 6, 2015
J&J Announces Completion of Cordis Divestiture to Cardinal Health
Johnson & Johnson has announced the completion of the divestiture of its Cordis business to Cardinal Health for an approximate value of $2 billion, subject to customary adjustments.
October 6, 2015
AmerisourceBergen to Acquire PharMEDium Healthcare Holdings, Inc.
AmerisourceBergen has announced that it has signed a definitive agreement to purchase PharMEDium Healthcare Holdings, Inc., the privately held provider of outsourced compounded sterile preparations (CSPs) to acute care hospitals in the United States, from Clayton, Dubilier & Rice for $2.575 billion in cash, subject to certain adjustments and on a cash-free, debt-free basis.
October 6, 2015
Akers Biosciences Launching BreathScan OxiChek and KetoChek Tests
Akers Biosciences, Inc. a medical device company focused on reducing the cost of healthcare through faster, easier diagnostics, has announced that all development specifications have been finalized and production has commenced for its two transformational breath tests designed for the health and wellness industry and consumers.
October 6, 2015
Merck: Results of Phase 3 Study of Investigational Chronic Hepatitis C Therapy
Merck has announced the publication of results from C-SURFER, the first Phase 31 clinical trial to investigate an all-oral, ribavirin-free chronic hepatitis C virus (HCV) treatment regimen in treatment-naïve and treatment-experienced patients with advanced chronic kidney disease (CKD) stages 4 or 5 and chronic HCV genotype 1 (GT1) infection.
October 6, 2015
USA: Aristada Approved to Treat Schizophrenia
Alkermes plcp has announced that the U.S. Food and Drug Administration (FDA) has approved Aristadatm (aripiprazole lauroxil) extended-release injectable suspension for the treatment of schizophrenia.
October 5, 2015
FDA orders three duodenoscopes manufacturers marketed in US
The U.S. Food and Drug Administration ordered on Monday the three manufacturers of duodenoscopes marketed in the U.S. to conduct postmarket surveillance studies to better understand how the devices are reprocessed in real-world settings.